Q-omics provides the consensus-scored NUP210P1 profile across patient tissues and cancer cell-line models. NUP210P1 expression is associated with patient survival in 5 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, NUP210P1 is differentially expressed in 1, with the highest sampling consensus in UCEC. Additionally, NUP210P1 RNA expression shows 6,331 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight HNSC, UCEC, and STAD as cancer lineages where NUP210P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for NUP210P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes NUP210P1 survival associations across molecular data types. NUP210P1 RNA expression shows survival associations in the most cancer types (5), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible NUP210P1 RNA expression–survival associations across cancer types. High NUP210P1 expression shows unfavorable associations in LAML, LUSC, BLCA and GBM, but favorable associations in HNSC. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .008). Together, the overview and detailed table identify HNSC as the clearest survival context for NUP210P1 RNA expression.
This table summarizes NUP210P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in UCEC for RNA.
This table ranks reproducible tumor–normal expression differences for NUP210P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. NUP210P1 shows higher tumor expression in UCEC. The UCEC box plot shows higher NUP210P1 RNA expression in tumor versus normal tissue (log2 FC = +0.125, t-test p = .037).
This table shows molecular features associated with NUP210P1 in patient tissues and cancer cell lines. In patient samples, NUP210P1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
